|
Volumn 41, Issue SUPPL. 1, 1996, Pages
|
A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure
|
Author keywords
betaxolol; brimonidine tartrate; ocular hypertension; open angle glaucoma
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BETAXOLOL;
BRIMONIDINE;
ADULT;
ARTICLE;
CARDIOVASCULAR EFFECT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG SELECTIVITY;
EYE TOXICITY;
FATIGUE;
FEMALE;
GLAUCOMA;
HEADACHE;
HUMAN;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE ABNORMALITY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MYALGIA;
OPEN ANGLE GLAUCOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
|
EID: 0029731441
PISSN: 00396257
EISSN: None
Source Type: Journal
DOI: 10.1016/s0039-6257(96)82030-3 Document Type: Article |
Times cited : (127)
|
References (0)
|